578 related articles for article (PubMed ID: 30598555)
1. CRISPR RNA-guided autonomous delivery of Cas9.
Wilkinson RA; Martin C; Nemudryi AA; Wiedenheft B
Nat Struct Mol Biol; 2019 Jan; 26(1):14-24. PubMed ID: 30598555
[TBL] [Abstract][Full Text] [Related]
2. CRISPR: development of a technology and its applications.
Derry WB
FEBS J; 2021 Jan; 288(2):358-359. PubMed ID: 33300275
[TBL] [Abstract][Full Text] [Related]
3. CRISPR-Cas9 in genome editing: Its function and medical applications.
Khadempar S; Familghadakchi S; Motlagh RA; Farahani N; Dashtiahangar M; Rezaei H; Gheibi Hayat SM
J Cell Physiol; 2019 May; 234(5):5751-5761. PubMed ID: 30362544
[TBL] [Abstract][Full Text] [Related]
4. Shooting the messenger: RNA-targetting CRISPR-Cas systems.
Zhu Y; Klompe SE; Vlot M; van der Oost J; Staals RHJ
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29748239
[TBL] [Abstract][Full Text] [Related]
5. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.
Yamamoto A; Ishida T; Yoshimura M; Kimura Y; Sawa S
Plant Cell Physiol; 2019 Oct; 60(10):2255-2262. PubMed ID: 31198958
[TBL] [Abstract][Full Text] [Related]
6. CRISPR-Cas systems: ushering in the new genome editing era.
Perez Rojo F; Nyman RKM; Johnson AAT; Navarro MP; Ryan MH; Erskine W; Kaur P
Bioengineered; 2018; 9(1):214-221. PubMed ID: 29968520
[TBL] [Abstract][Full Text] [Related]
7. RNA-dependent RNA targeting by CRISPR-Cas9.
Strutt SC; Torrez RM; Kaya E; Negrete OA; Doudna JA
Elife; 2018 Jan; 7():. PubMed ID: 29303478
[TBL] [Abstract][Full Text] [Related]
8. Application of CRISPR-Cas9-Mediated Genome Editing for the Treatment of Myotonic Dystrophy Type 1.
Marsh S; Hanson B; Wood MJA; Varela MA; Roberts TC
Mol Ther; 2020 Dec; 28(12):2527-2539. PubMed ID: 33171139
[TBL] [Abstract][Full Text] [Related]
9. Editor's cut: DNA cleavage by CRISPR RNA-guided nucleases Cas9 and Cas12a.
Swartjes T; Staals RHJ; van der Oost J
Biochem Soc Trans; 2020 Feb; 48(1):207-219. PubMed ID: 31872209
[TBL] [Abstract][Full Text] [Related]
10. Optical Control of Genome Editing by Photoactivatable Cas9.
Otabe T; Nihongaki Y; Sato M
Methods Mol Biol; 2021; 2312():225-233. PubMed ID: 34228293
[TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas9 in Genome Editing and Beyond.
Wang H; La Russa M; Qi LS
Annu Rev Biochem; 2016 Jun; 85():227-64. PubMed ID: 27145843
[TBL] [Abstract][Full Text] [Related]
12. CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAs.
Coelho MA; De Braekeleer E; Firth M; Bista M; Lukasiak S; Cuomo ME; Taylor BJM
Nat Commun; 2020 Aug; 11(1):4132. PubMed ID: 32807781
[TBL] [Abstract][Full Text] [Related]
13. CRISPR-Cas9-Mediated Gene Silencing in Cultured Human Epithelia.
Gago S; Overton NLD; Bowyer P
Methods Mol Biol; 2021; 2260():37-47. PubMed ID: 33405030
[TBL] [Abstract][Full Text] [Related]
14. CRISPR-gRNA Design.
Pallarès Masmitjà M; Knödlseder N; Güell M
Methods Mol Biol; 2019; 1961():3-11. PubMed ID: 30912036
[TBL] [Abstract][Full Text] [Related]
15. Heavily and fully modified RNAs guide efficient SpyCas9-mediated genome editing.
Mir A; Alterman JF; Hassler MR; Debacker AJ; Hudgens E; Echeverria D; Brodsky MH; Khvorova A; Watts JK; Sontheimer EJ
Nat Commun; 2018 Jul; 9(1):2641. PubMed ID: 29980686
[TBL] [Abstract][Full Text] [Related]
16. Type II anti-CRISPR proteins as a new tool for synthetic biology.
Zhang Y; Marchisio MA
RNA Biol; 2021 Aug; 18(8):1085-1098. PubMed ID: 32991234
[TBL] [Abstract][Full Text] [Related]
17. Phage AcrIIA2 DNA Mimicry: Structural Basis of the CRISPR and Anti-CRISPR Arms Race.
Liu L; Yin M; Wang M; Wang Y
Mol Cell; 2019 Feb; 73(3):611-620.e3. PubMed ID: 30606466
[TBL] [Abstract][Full Text] [Related]
18. Co-expression of Cas9 and single-guided RNAs in
Qiao J; Li W; Lin S; Sun W; Ma L; Liu Y
Commun Biol; 2019; 2():161. PubMed ID: 31069270
[TBL] [Abstract][Full Text] [Related]
19. CRISPR/Cas9 gene-editing strategies in cardiovascular cells.
Vermersch E; Jouve C; Hulot JS
Cardiovasc Res; 2020 Apr; 116(5):894-907. PubMed ID: 31584620
[TBL] [Abstract][Full Text] [Related]
20. Disabling Cas9 by an anti-CRISPR DNA mimic.
Shin J; Jiang F; Liu JJ; Bray NL; Rauch BJ; Baik SH; Nogales E; Bondy-Denomy J; Corn JE; Doudna JA
Sci Adv; 2017 Jul; 3(7):e1701620. PubMed ID: 28706995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]